SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001217624-09-000012
Filing Date
2009-01-07
Accepted
2009-01-07 17:14:51
Documents
1
Period of Report
2009-01-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4480
  Complete submission text file 0001217624-09-000012.txt   6239
Mailing Address 505 PENOBSCOT DR REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR REDWOOD CITY CA 94063 6503969500
GENELABS TECHNOLOGIES INC /CA (Issuer) CIK: 0000874443 (see all company filings)

IRS No.: 943010150 | State of Incorp.: CA | Fiscal Year End: 0131
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address C/O OXIGENE INC 321 ARSENAL STREET WATERTOWN MA 02472
DRISCOLL FREDERICK W (Reporting) CIK: 0001129890 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19222 | Film No.: 09513828